Can Radiomics Analyses in F-18-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

---

Araz M., Soydal Ç., Gündüz P., Kırmızı B. A., Bakırarar B., Sak S., ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.31, sa.1, ss.49-56, 2022 (ESCI, Scopus, TRDizin)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 31 Sayı: 1
• Basım Tarihi: 2022
• Doi Numarası: 10.4274/mirt.galenos.2022.59140
• Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.49-56
• Anahtar Kelimeler: Breast cancer, PET/CT, fluorodeoxyglucose, hormone receptor, CANCER, ESTROGEN, FEATURES, VOLUME, SUV
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Ankara Üniversitesi Adresli: Evet

Özet

Objectives: This study aimed to investigate the role of preoperative 'fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/ computed tomography (PET/CT) radiomics features and metabolic parameters of primary breast tumors in predicting hormone receptor (HR) positivity.